Publicado feb 12, 2018



PLUMX
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar


Nelci Astrid Becerra Martínez

Pilar García Padilla

##plugins.themes.bootstrap3.article.details##

Resumen

El habitual proyecto de definir una fecha para dejar de fumar abruptamente ha sido refutado por muchos pacientes que han mostrado interés por reducir su consumo de modo gradual. La reducción progresiva utilizando terapia sustitutiva con nicotina previa a la cesación permitiría tratar a un mayor número de fumadores. El artículo presenta el caso de un paciente con alta dependencia a la nicotina, interesado en dejar de fumar, pero no de manera abrupta.

Keywords

smoking, smoking cessation, harm reductionhábito de fumar, cese del tabaquismo, reducción del daño

References
1. US Department of Health and Human Services. The health consequences of smoking: A report of the surgeon general. Atlanta, (GA): U.S. Department of Health and Human Services, Centers for Diseases Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.

2. World Health Organization. Report on the global tobacco epidemic. Switzerland: WHO; 2011.

3. U.S. Department of Health and Human Services. The health consequences of smoking—50 years of progress: A report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. Printed with corrections, January 2014.

4. American Cancer Society and World Lung Foundation. The Tobacco Atlas. 2015.

5. Pichon A, Bardach A, Caporale J, Augustovski F, Alcaraz A, Navia M, et al. Health and economic burden of tobacco use in seven Latin American countries: Results from a microsimulation Health Economic Model (HEM). Value in Health 16. 2013:A665–A728.

6. Fiore MC, Jaén CR, Baker TB, Bailey WC. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2008.

7. Organización Mundial de la Salud. Strengthening health systems for treating tobacco dependence in primary care. Part 1: Training forpolicy. Washington: OMS; 2013.

8. Aveyard P, Raw M. Improving smoking cessation approaches at the individual level. Tob Control [internet]. 2012;21(2):252-57. Disponible en: http://tobaccocontrol.bmj.com/content/21/2/252.full

9. Alba LH, Murillo R, Becerra N, Páez N, Cañas A, Mosquera Ca, Castillo JS, Camacho N, Gómez J, García-Herreros P, Bernal LG. Recomendaciones para la cesación de la adicción al tabaco en Colombia. Biomédica. 2013;33:186-204.

10. Guichenez P, Clauzel I, Cungi C, et al. The contribution of cognitive-behavioural therapies to smoking cessation [in French]. Rev Mal Respir. 2007;24(2):171-82.

11. Fernández Arias I. Eficacia de la terapia cognitivo conductual, los parches de nicotina y su combinación para dejar de fumar. Tesis Doctoral, Universidad Complutense de Madrid, España; 2012.

12. Becoña E, Fernández del Río E, López A, Martínez U, Martínez C, Rodríguez RA. El tratamiento psicológico de la dependencia del tabaco: Eficacia, barreras y retos para el futuro. Papeles del Psicólogo. 2014;35(3):161-8.

13. Encuesta Millward Brown. Mayo 2006. Barcelona.

14. Fagerström KO. Interventions for treatment-resistant smokers. Nicotine Tob Res. 1999;1:S201-5.

15. Fagerström KO. Can reduced smoking be a way for smokers not interested in quitting to actually quit? Respiration. 2005;72:216-20.

16. Ebbert JO, Hughes JR, West RJ, et al. Effect of varenicline on smoking cessation through smoking reduction: a randomised clinical trial. JAMA. 2015;313:687-94.

17. Jiménez Ruiz CA, Fagerström KO. Reducción hasta dejarlo: árbol de decisión. Prev Tab. 2006;8(Supl. 1):34-7.

18. Hughes JR, Carpenter MJ. The feasibility of smoking reduction: an update. Addiction. 2005;100:1074-89.

19. Wennike P, Danielsson T, Landfeldt B, Westin A, Tonnesen P. Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction. 2003;98:1395-1402.

20. Batra A, Klingler K, Landfeldt B, Friederich HM, Westin A, Danielsson T. Smoking reduction treatment with 4-mg nicotine gum: A double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther. 2005;78:689-96.

21. Rennard SI, Glover E, Leischow S, Daughton DM, Glover P, Muramoto M, Franzon M, Danielsson T, Landfeldt B, Westin A. Efficacy of nicotine inhaler in smoking reduction: a double-blind, randomized trial. Nicotine Tob Res. 2006;8:555-64.

22. Kralikova E, Kozak J, Rasmussen T, et al. Smoking cessation or reduction with nicotine replacement therapy: A placebo-controlled double blind trial with nicotine gum and inhaler. BMC Public Health. 2009;9:433.

23. Wennike P, Danielsson T, Landfeldt B, Westin A, Tønnesen P. Smoking reduction promotes smoking cessation: results from a double blind, randomised, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction. 2003;98:1395-1402.

24. Glasgow RE, Gaglio B, France EK, Marcus Al, Riley KM. et al. Do behavioural smoking reduction approaches reach more or different smokers?: Two studies similar answers. Add Beh. 2006;31:510-8.

25. Hughes JR, Callas PW, Peters EN. Interest in gradual reduction. Nic Tob Res. 2007;6:671-5.

26. Stead LF, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database Systems Review. 2007;18(3):CD 005231.

27. Sophia SC, Chan D. Leung A, Abdullah V, Wong A, Hedley L. A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking. Addiction. 106;1155-63.add

28. Jiménez Ruiz CA, Riesco Miranda JA, Ramos Pinedo A, Barrueco Ferrero M, Solano Reina S, de Granda Orive JI, et al. Recomendaciones para el tratamiento farmacológico del tabaquismo: propuesta de financiación. Arch Bronconeumol. 2008;44(4):213-9.

29. Fagerström KO, Hughes RJ. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: A review. Nic Tob Res. 2002;4:S155-61.

30. Lindson-Hawley N, Hartmann-Boyce J, Fanshawe T, Begh R, Farley A, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database. Octubre, 2016.
Cómo citar
Becerra Martínez, N. A., & García Padilla, P. (2018). Terapia de remplazo nicotínico asociada con reducción gradual del consumo de cigarrillos como estrategia de cesación de tabaco. Reporte de caso. Universitas Medica, 59(1). https://doi.org/10.11144/Javeriana.umed59-1.taba
Sección
Reportes de caso